Technical Analysis for VXRT - Vaxart, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 1.00 | -6.54% | -0.07 |
VXRT closed down 6.54 percent on Wednesday, February 8, 2023, on 44 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: Feb 22
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
180 Bearish Setup | Bearish Swing Setup | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
MACD Bearish Centerline Cross | Bearish | -6.54% | |
Crossed Above 50 DMA | Bullish | -6.54% | |
Lizard Bullish | Bullish Day Trade Setup | -6.54% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Down 5% | about 7 hours ago |
Lower Bollinger Band Support | about 7 hours ago |
Fell Below Previous Day's Low | about 10 hours ago |
Fell Below Lower Bollinger Band | about 10 hours ago |
60 Minute Opening Range Breakdown | about 10 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/22/2023
Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Influenza Vaccines Coronavirus Vaccination Hepatitis B Papillomavirus Seasonal Influenza HPV Human Papilloma Virus
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Influenza Vaccines Coronavirus Vaccination Hepatitis B Papillomavirus Seasonal Influenza HPV Human Papilloma Virus
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.43 |
52 Week Low | 0.7316 |
Average Volume | 3,152,840 |
200-Day Moving Average | 2.50 |
50-Day Moving Average | 1.06 |
20-Day Moving Average | 1.10 |
10-Day Moving Average | 1.08 |
Average True Range | 0.08 |
RSI | 42.20 |
ADX | 19.82 |
+DI | 19.00 |
-DI | 16.10 |
Chandelier Exit (Long, 3 ATRs) | 1.01 |
Chandelier Exit (Short, 3 ATRs) | 1.22 |
Upper Bollinger Bands | 1.20 |
Lower Bollinger Band | 1.00 |
Percent B (%b) | 0.0 |
BandWidth | 17.90 |
MACD Line | -0.01 |
MACD Signal Line | 0.00 |
MACD Histogram | -0.0048 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.11 | ||||
Resistance 3 (R3) | 1.12 | 1.09 | 1.09 | ||
Resistance 2 (R2) | 1.09 | 1.07 | 1.09 | 1.08 | |
Resistance 1 (R1) | 1.05 | 1.05 | 1.04 | 1.04 | 1.08 |
Pivot Point | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 |
Support 1 (S1) | 0.98 | 1.00 | 0.97 | 0.97 | 0.92 |
Support 2 (S2) | 0.95 | 0.98 | 0.95 | 0.92 | |
Support 3 (S3) | 0.91 | 0.95 | 0.91 | ||
Support 4 (S4) | 0.90 |